
Sign up to save your podcasts
Or
Introducing HIV: Racing to Identify a Killer from Incubation.
Follow the show: Incubation
After four decades of dedicated research on HIV, scientists have made extraordinary progress in treating the disease. But we still don’t have a vaccine or a cure. On today’s show, we’re joined by two veteran scientists who have dedicated their careers to HIV research. First up is Christine Rouzioux, a virologist from the Nobel Prize winning team of scientists who first identified the HIV virus. For the second half of the show we talk with Richard Koup from the National Institutes of Health, who explains why it’s so hard to create an HIV vaccine.
See omnystudio.com/listener for privacy information.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
4.7
718718 ratings
Introducing HIV: Racing to Identify a Killer from Incubation.
Follow the show: Incubation
After four decades of dedicated research on HIV, scientists have made extraordinary progress in treating the disease. But we still don’t have a vaccine or a cure. On today’s show, we’re joined by two veteran scientists who have dedicated their careers to HIV research. First up is Christine Rouzioux, a virologist from the Nobel Prize winning team of scientists who first identified the HIV virus. For the second half of the show we talk with Richard Koup from the National Institutes of Health, who explains why it’s so hard to create an HIV vaccine.
See omnystudio.com/listener for privacy information.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
68,738 Listeners
59,310 Listeners
9,063 Listeners
10,314 Listeners
12,618 Listeners
57,457 Listeners
5,496 Listeners
3,732 Listeners
3,661 Listeners
1,291 Listeners
2,600 Listeners
12,208 Listeners
2,142 Listeners
3,318 Listeners
2,110 Listeners